Trainings and Resources

Substance use and its progression to impairment, loss of control, and development of substance use disorders is a significant problem for adolescents and young adults. This presentation will provide an overview of developmentally-informed approaches to engaging youth and their families in treatment. Learning Objectives: Recognize motivational approaches to working with substance involved youth Identify approaches to engaging families of substance involved youth Speaker: Marc Fishman, MD

In addition to an historic level of funding for its rural programs in 2021, the agency’s focus on health equity and meeting the needs of the underserved during the pandemic brought more than $8 billion in grants and other resources to communities across the country and its territories last year. Among several actions taken in January 2022, HRSA welcomed new leadership, awarded funds to address burnout for the nation’s health care workforce, and continued to distribute Provider Relief Fund payments.

Opioid use disorder (OUD) is a public health crisis affecting women, men, children, and society.1 Women with OUD have unique care needs and require a broad range of medical, behavioral health, and social services to meet these needs. Care coordination is important to manage the array of services that might be delivered to women in different settings. Without care coordination, women with OUD might struggle to access the services they need to get treatment and maintain recovery.

The workshop presented strategies to integrate HIV, hepatitis, and sexual health concerns into services for PWID. The session will focus on communication skills, assessment techniques, and building motivation among PWID to make healthier choices. Mr. Sacco looked at programmatic and clinical-level integration strategies and offered participants an opportunity to assess current service delivery models and develop a plan to enhance care. Mrs. Bell and Ms. Chavis intrdoduce participants to resources and funding opportunities available through HRSA’s HIV/AIDS Bureau (HAB).

Drug overdose deaths in the United States hit a record high in 2017, with an estimated 72,000  deaths. Over two-thirds of those deaths, roughly 47,600, were due to opioids.These  staggering numbers continued in 2018, as over 67,000 drug overdose deaths occurred, and  opioids were involved in rough 46,800 of those overdose deaths. This roadmap highlights existing state efforts and serves as a policy development tool for Governors and state officials seeking to improve coordination and bolster existing efforts across state agencies to address OUD among people involved in the justice system by expanding access to evidence-based medications.

Medication-assisted treatment for substance use disorders has a new venue: the grocery store. Ideal Option, which operates more than 60 office-based opioid treatment clinics across 10 states, has partnered with Safeway, one of the nation’s largest grocery retailers, to provide its services inside the wellness center at a Safeway store in Vancouver, Washington, a suburb 10 miles north of Portland, Oregon.

In 2015, 33,091 persons in the United States died from an opioid-related drug overdose.The epidemic of opioid overdose deaths has led to expanding the use of naloxone in community settings by non–medically trained bystanders who are often people who use drugs (PWUD). Since 2013, illicitly manufactured fentanyl (IMF), fentanyl analogs, and other synthetic opioids have played an increasing role in overdose deaths in the United States. Illicitly manufactured fentanyl (IMF) prevalence has increased. However, there is uncertainty about naloxone dose(s) used by nonmedical bystanders to reverse opioid overdoses in the context of increasing IMF. 

Grantee/Partner Video Showcase